Aster DM Healthcare Limited
NSEI:ASTERDM Voorraadrapport
Marktkapitalisatie: ₹218.2b
Aster DM Healthcare Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6 Aster DM Healthcare heeft een totaal eigen vermogen van ₹36.0B en een totale schuld van ₹5.9B, wat de schuld-eigenvermogensverhouding op 16.4% brengt. De totale activa en totale passiva bedragen respectievelijk ₹66.9B en ₹30.9B. De EBIT Aster DM Healthcare is ₹4.6B waardoor de rentedekking 4.3 is. Het heeft contanten en kortetermijnbeleggingen van ₹15.8B.
Belangrijke informatie
16.4%
Verhouding schuld/eigen vermogen
Rente dekkingsratio 4.3x Contant ₹15.78b Aandelen ₹36.02b Totaal verplichtingen ₹30.86b Totaal activa ₹66.88b
Recente financiële gezondheidsupdates
Toon alle updates
Aster DM Healthcare and Quality Care India Merger Talks Reportedly Enters Final Lap Nov 11
Aster DM Healthcare's (NSE:ASTERDM) Sluggish Earnings Might Be Just The Beginning Of Its Problems Oct 31
Price target increased by 9.1% to ₹463 Oct 25
Second quarter 2025 earnings: EPS and revenues exceed analyst expectations Oct 24
Aster DM Healthcare Limited to Report Q2, 2025 Results on Oct 23, 2024 Oct 17
Here's What's Concerning About Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital Oct 14
Consensus EPS estimates fall by 13% Oct 10
Aster DM Healthcare Appoints Mohamed Alshamari as CEO of Aster Hospitals and Clinics in Saudi Arabia Oct 08 Aster DM Healthcare and Quality CARE Reportedly in Final Stages of Negotiations and Expects Deal to be Sign by the End of September 2024
Aster DM Healthcare Limited Announces Executive Changes Sep 11
High number of new directors Sep 10 Aster DM Healthcare Limited Approves Board Appointments
Upcoming dividend of ₹2.00 per share Aug 15
Blackstone Reportedly in Talks with the Promoters of Aster DM Healthcare to Merge Quality Care India with Aster Aug 06
First quarter 2025 earnings released: EPS: ₹1.49 (vs ₹0.10 in 1Q 2024) Aug 01
Aster DM Healthcare Limited to Report Q1, 2025 Results on Jul 31, 2024 Jul 25
Aster DM Healthcare Limited's (NSE:ASTERDM) Popularity With Investors Is Under Threat From Overpricing Jul 20
Capital Allocation Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Ideal Jun 23 Olympus Capital Asia Investments to Sell Up to 10% Stake in Aster DM Healthcare through Block Deals Jun 21
Consensus EPS estimates fall by 93%, revenue upgraded Jun 04
Aster DM Healthcare Limited, Annual General Meeting, Aug 29, 2024 May 31
Price target decreased by 7.3% to ₹453 May 30
Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 May 30
Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt May 30
Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 May 29
Full year 2024 earnings released: EPS: ₹2.46 (vs ₹8.54 in FY 2023) May 29
Aster DM Healthcare Limited to Report Q4, 2024 Results on May 28, 2024 May 24 Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel
New minor risk - Share price stability Apr 23
Investor sentiment deteriorates as stock falls 23% Apr 23
Aster DM Healthcare Limited Declares Special Dividend Apr 14
With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For Apr 14
Aster DM Healthcare Limited Declares Special Dividend Apr 12
Investor sentiment improves as stock rises 19% Apr 08
Aster DM Healthcare Limited Announces Board Changes Apr 03
Olympus Capital Reportedly Plans Stake Sale in Aster DM Healthcare Mar 27
Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate Mar 27
Price target increased by 9.3% to ₹459 Feb 12
Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Feb 12
New major risk - Financial position Feb 12
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Feb 09
Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly Feb 07
Aster DM Healthcare Limited to Report Q3, 2024 Results on Feb 08, 2024 Feb 03
There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital Jan 19
Now 20% undervalued Jan 01
KKR, Ontario Teachers' Pension Plan and Care Hospitals Reportedly Submit Non-Binding Term Sheets to Acquire Stake in the Indian Business of Aster DM Healthcare Dec 13
Aster DM Healthcare to Fuel India Expansion Through Buyouts Dec 08
Now 20% undervalued Dec 07
New minor risk - Share price stability Dec 04
Consensus EPS estimates fall by 16% Dec 01
Price target increased by 18% to ₹397 Nov 30
Investor sentiment improves as stock rises 17% Nov 29
Second quarter 2024 earnings released: ₹0.62 loss per share (vs ₹0.93 profit in 2Q 2023) Nov 15
Aster's India Unit Reportedly Draws Suitors Valuing Business At $1.5 Billion Oct 12
New major risk - Financial position Aug 17
Aster DM Healthcare Limited Announces Resignation Anoop Moopen as Non-Executive Director Aug 15
Full year 2023 earnings: EPS misses analyst expectations Aug 10
Aster DM Healthcare Limited to Report Q1, 2024 Results on Aug 14, 2023 Aug 08
Aster DM Healthcare Limited, Annual General Meeting, Aug 31, 2023 Aug 04
Aster Healthcare's Promoters Reportedly in Talks with Private Equity Groups, Look to Sell India Business Jul 08
Aster DM Healthcare Confirms Talks with Fajr Capital, Others on Gulf Business Jul 06
Investor sentiment improves as stock rises 16% Jul 04
Consensus EPS estimates fall by 15%, revenue upgraded Jun 01
Price target increased by 7.6% to ₹291 May 29
Aster Eye $300 million India Stake Sale May 27
Full year 2023 earnings released: EPS: ₹8.54 (vs ₹10.58 in FY 2022) May 26
Aster DM Healthcare Limited Announces Resignation of Sridar Arvamudhan Iyengar as Non-Executive Independent Director May 25
Aster DM Healthcare Limited to Report Q4, 2023 Results on May 25, 2023 May 20
Third quarter 2023 earnings released: EPS: ₹2.80 (vs ₹2.98 in 3Q 2022) Feb 15
Aster DM Healthcare Limited Appoints Rahul Kadavakolu as Group Chief Marketing Officer Feb 10
Aster DM Healthcare Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 09
Aster DM Healthcare Limited Announces Resignation of Sreenath Pocha Reddy as Group Chief Financial Officer, Effective 5 January 2023 Jan 06
Consensus forecasts updated Nov 17
Price target increased to ₹275 Nov 16
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 16
Less than half of directors are independent Nov 16
Aster DM Healthcare Limited Announces Retirement of Prof. Biju Varkkey as Non-Executive Independent Director Nov 12
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 11
Aster DM Healthcare Limited to Report Q2, 2023 Results on Nov 10, 2022 Nov 05
Aster DM Healthcare Limited (NSEI:ASTERDM) entered into share purchase agreement to acquire 22.69% stake in Sri SaiNatha Multi Speciality Hospitals Pvt. Ltd from promoters and their relatives for INR 250 million. Oct 21
Investor sentiment improved over the past week Sep 08
Aster DM Healthcare Limited to Report Q1, 2023 Results on Aug 11, 2022 Aug 07
Full year 2022 earnings: EPS and revenues exceed analyst expectations Aug 04
Investor sentiment improved over the past week Jul 19
Investor sentiment improved over the past week May 31
Aster DM Healthcare Limited, Annual General Meeting, Aug 25, 2022 May 25
Full year 2022 earnings: EPS and revenues exceed analyst expectations May 25
Aster DM Healthcare Limited to Report Q4, 2022 Results on May 24, 2022 May 17
Less than half of directors are independent Apr 27
Consensus forecasts updated Apr 14
Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)? Apr 03
Investor sentiment improved over the past week Mar 28
Is Aster DM Healthcare Limited (NSE:ASTERDM) Trading At A 42% Discount? Mar 02
Third quarter 2022 earnings: EPS and revenues exceed analyst expectations Feb 09
Aster DM Healthcare Limited to Report Q3, 2022 Results on Feb 08, 2022 Feb 03
Should You Investigate Aster DM Healthcare Limited (NSE:ASTERDM) At ₹186? Dec 17
Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹21.0B ) ASTERDM } overtreffen de korte termijn passiva ( ₹10.9B ).
Langlopende schulden: De kortetermijnactiva ASTERDM ( ₹21.0B ) overtreffen de langetermijnschulden ( ₹20.0B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: ASTERDM heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van ASTERDM is de afgelopen 5 jaar gedaald van 72.4% naar 16.4%.
Schuldendekking: De operationele kasstroom van ASTERDM is negatief, waardoor de schuld niet goed gedekt is.
Rentedekking: De rentebetalingen op de schuld van ASTERDM worden goed gedekt door EBIT ( 4.3 x dekking).
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
